Reckitt Benckiser Group plc (OTCMKTS:RBGLY – Get Free Report) saw a significant drop in short interest in the month of December. As of December 15th, there was short interest totalling 4,300 shares, a drop of 97.2% from the November 30th total of 154,900 shares. Based on an average daily trading volume, of 721,100 shares, the days-to-cover ratio is presently 0.0 days.
Reckitt Benckiser Group Stock Up 0.1 %
Reckitt Benckiser Group stock traded up $0.01 during midday trading on Thursday, reaching $12.05. The company’s stock had a trading volume of 242,691 shares, compared to its average volume of 846,842. Reckitt Benckiser Group has a 52-week low of $10.24 and a 52-week high of $15.03. The company has a current ratio of 0.69, a quick ratio of 0.47 and a debt-to-equity ratio of 0.97. The stock’s 50-day simple moving average is $12.32 and its 200-day simple moving average is $11.77.
Analysts Set New Price Targets
RBGLY has been the subject of a number of analyst reports. UBS Group upgraded Reckitt Benckiser Group to a “strong-buy” rating in a report on Wednesday, September 18th. JPMorgan Chase & Co. downgraded Reckitt Benckiser Group from an “overweight” rating to a “neutral” rating in a research report on Thursday, August 29th. Citigroup upgraded shares of Reckitt Benckiser Group to a “strong-buy” rating in a report on Tuesday, October 1st. Hsbc Global Res upgraded shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a report on Wednesday, December 11th. Finally, Sanford C. Bernstein lowered shares of Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 4th. Three equities research analysts have rated the stock with a hold rating, one has issued a buy rating and four have given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy”.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Recommended Stories
- Five stocks we like better than Reckitt Benckiser Group
- What is the Nikkei 225 index?
- Top 3 Investment Themes to Watch for in 2025
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- The Most Important Warren Buffett Stock for Investors: His Own
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.